Medline Inc.
L10
| 09/27/2025 | 06/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.33% | 1.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.33% | 1.79% | |||
| Cost of Revenue | 5.20% | 1.64% | |||
| Gross Profit | -1.57% | 2.17% | |||
| SG&A Expenses | 2.76% | -0.64% | |||
| Depreciation & Amortization | 0.57% | 0.28% | |||
| Other Operating Expenses | -42.86% | -6.67% | |||
| Total Operating Expenses | 4.54% | 1.18% | |||
| Operating Income | -8.74% | 8.26% | |||
| Income Before Tax | -3.90% | 3.01% | |||
| Income Tax Expenses | -11.54% | 23.81% | |||
| Earnings from Continuing Operations | -3.30% | 1.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.30% | 1.68% | |||
| EBIT | -8.74% | 8.26% | |||
| EBITDA | -5.75% | 5.79% | |||
| EPS Basic | -3.16% | -- | |||
| Normalized Basic EPS | 1.61% | -- | |||
| EPS Diluted | -3.16% | -- | |||
| Normalized Diluted EPS | 1.61% | -- | |||
| Average Basic Shares Outstanding | -0.13% | -- | |||
| Average Diluted Shares Outstanding | -0.13% | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.19% | -0.02% | |||